TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/14/2023
Back to search
Official data from USPTO
TEXAS ONCOLOGY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
10/14/2023
Trademark type
Combined
Nice classes
44
Filing date
03/23/2007
Registration date
05/27/2008
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/02/2018
Last transaction
10/14/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
08/03/2006
First use in commerce
08/03/2006
Drawing code
3
Owner type
99
Owner location
Dallas, TX
Examiner
PRICE, WANDA
Law office
M20
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of the words "TEXAS ONCOLOGY" with a star design.
Holders and representatives
Holders
Texas Oncology, P.A.
Representatives
Michael M. Zadrozny Zadrozny IP, LLC
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Medical services
Publications
History of USPTO decisions and trademark events.
29 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/14/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/14/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/20/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/20/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/20/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/02/2018
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/02/2018
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/02/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/01/2018
E89R
TEAS SECTION 8 & 9 RECEIVED
05/23/2018
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED
10/15/2013
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/15/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/15/2013
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
10/07/2013
E815
TEAS SECTION 8 & 15 RECEIVED
10/07/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
05/27/2008
PUBO
PUBLISHED FOR OPPOSITION
03/11/2008
NPUB
NOTICE OF PUBLICATION
02/20/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/04/2008
ALIE
ASSIGNED TO LIE
02/04/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/22/2007
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
12/20/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/20/2007
CNRT
NON-FINAL ACTION MAILED
07/02/2007
CNRT
NON-FINAL ACTION WRITTEN
06/29/2007
DOCK
ASSIGNED TO EXAMINER
06/29/2007
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
03/29/2007
NWAP
NEW APPLICATION ENTERED
03/28/2007
Continuous trademark protection
Get notified about every new filing that threatens TEXAS ONCOLOGY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.